INTRODUCTION
The epidemiology of prostate cancer in the United States is characterized by disparities in survival by race and place. African Americans have worse prostate cancerspecific survival rates than those of Whites, Hispanics and other racial/ethnic groups (1) . African Americans also tend to present with more advanced and higher histologic grade tumors than other racial/ethnic groups, and taking these differences into account explains some but not all of the disparity in survival (2) . Consequently, researchers have investigated biological predisposition, lifestyle, and treatment differences as other component causes of U.S. racial/ethnic disparities in survival (3, 4) . prostate cancer. These factors could include, among other things, social determinants of health and disease.
Social determinants of prostate cancer-specific survival and their relation to racial/ethnic disparities are poorly understood. Area-level socioeconomic status (SES) is a plausible prognostic factor in prostate cancer, because gradients thereof associate with inequalities in geographical access to healthcare, individual-level insurance status, and other circumstances that can lead to clinically important variation in cancer detection, staging, treatment, and long-term cancer care (7) (8) (9) . However, in contrast to individual-level SES, the relation between area-level SES and racial/ethnic disparities in prostate cancer-specific survival has been more difficult to establish (10) . Race and ethnicity are often highly correlated with aggregate measures of socioeconomic status such as mean per capita household income (11). Furthermore, area-level SES is multidimensional, composed of poverty, housing, employment, education, racial composition, and occupational domains (12) . However, studies of area-level SES and prostate cancer survival that incorporate multidimensional global measures of SES are scarce (13, 14) . Also, given the likely complexity of the area-level SES and cancer survival relationship, it would be desirable to link the study design to a conceptual framework or mechanistic model that guides the selection and analysis of the relevant variables (15) . Therefore, the primary objective of this study was to analyze whether area-level socioeconomic status is a prognostic factor in men diagnosed with prostate cancer using a multidimensional global measure of area-level SES. The analysis was not focused on the geospatial dimension of an association between area-level SES and prostate cancer-specific survival. Rather, it was concerned with area-level of SES as a non-spatial characteristic of the environment. The secondary objective was to determine whether an association helped explain observed racial/ethnic disparities in prostate cancer-specific survival. We hypothesized that the socioeconomic status of the census tract of residence at the time of a diagnosis of prostate cancer would be an independent predictor of cancer-specific survival after accounting for patient demographic and clinical characteristics, prognostic tumor parameters, first-course treatment and healthcare setting, and that this association would help explain disparities in prostate cancer-specific survival between African American and non-Hispanic whites. These hypotheses were tested in a retrospective cohort of men diagnosed with prostate cancer in the Chicago area using an analysis guided by the MacArthur Model for the Pathway from Socioeconomic Status to Health (16) . In this model, the association of race/ethnicity with health is mediated by individual-level SES, environmental resources and constraints (e.g., neighborhood factors) and psychosocial factors. These, in turn, influence downstream factors that are more proximal determinants of health. These factors include access to health care, the physical environment, health behaviors, and biologic responses that may determine the development and course of disease.
MATERIALS AND METHODS

Cohort Selection and Baseline Variables
Cohort selection and the baseline variables collected have been described in detail previously (17) . Briefly, our cohort consisted of all African-American and nonHispanic white men diagnosed with adenocarcinoma of the prostate (International (18) . Two of the medical centers were private university-affiliated, and two were in the Veterans Health Administration (VA) system. Cases were identified through the tumor registry at each facility. Data were extracted from medical records by trained medical records abstractors blinded to the hypotheses under study. These data (20, 21) . Comorbidity at the time of diagnosis was measured using the Charlson index (22) . We also created an indicator variable for healthcare system, VA vs. the private sector. This variable reflects access independent of the ability to pay ('equal access') vs. access dependent on the ability to pay. The measure of census tract-level SES used in this analysis was based on one derived in the Chicago area population by Browning and Cagney (23) . They examined the social context of Chicago neighborhoods in detail using information from the 1990 U.S. decennial census. A factor analysis of 10 variables tapping into various aspects of structural disadvantage revealed a dimension they referred to as "concentrated disadvantage." The measure was dominated by high factor loadings for percentage in census tract population living below the poverty line, unemployed, residing in a femaleheaded household, under age 18 years (factor loading of 0.85 for each), and African American (factor loading of 0.60). The resulting formula weighted each variable by its factor loading: 0.85 x (% in poverty + %unemployed + % in female-headed household + % age under 18 years) + 0.60 x (% African-American). The result has been shown to predict self-rated physical health and asthma severity in the general Chicago population (23, 24) .
Multidimensional Global Measure of SES at the Census Tract Level
In our study, we did not use percentage of African-American ethnicity to calculate tract-level concentrated disadvantage. Firstly, the major focus of our analysis was to identify determinants of prostate cancer survival disparities between African-American and non-Hispanic white males in the Chicago area. Secondly, we wanted to analyze our area-based measure of SES as an independent prognostic variable rather than a confounder, and the concentrated disadvantage measure using the original Browning and Cagney formula was likely highly correlated with the racial composition of the census tracts. Also, additional analyses in our study cohort, which consisted primarily of older men with prostate cancer, supported substituting the percentage under age 18 years with (100 -% college graduate). Consequently, the formula we used to calculate census tract-level concentrated disadvantage scores based on 1990 U.S. census data was a simple sum of the following: % in poverty + % unemployed + % female-headed households + (100 -% college graduate) (25) . As with the original formula, this modified version is a multidimensional area-based measure of SES, and it does not have an analogous value at the individual level. Therefore, the results of analyses of its impact on the prognosis of individual patients are less susceptible to ecologic confounding compared to those based on a single-variable aggregate measure of SES (e.g., percent poverty), especially in the context of the research questions being addressed in this study (26, 27) . before 1999 and the tenth revision for deaths occurring thereafter (28, 29) The comparability ratio for malignant neoplasms of the prostate between the tenth and ninth is 1.0134 (30) .
Vital Status and Underlying Cause of Death
Exclusions
Of the 1007 cases with medical records available for review, 174 were excluded for the following reasons: cancers were T1a-stage lesions, which are considered clinically insignificant (n = 90); incomplete data (n = 53); and the case's residential address at diagnosis could not be matched to its' corresponding census tract geocode (n = 31). This left 833 cases (320 African Americans and 513 non-Hispanic whites) for statistical analysis.
Nesting of Cases by Medical Center and by Census Tract
Our sampling frame was at the medical center level. The number of cases at each of the four medical centers was 169, 208, 222, and 234, respectively. The 833 cases represented 562 unique census tracts. Of these census tracts, 47% contained 1 case, 26% contained 2 cases, and the rest contained 3 to 8 cases.
Statistical Analysis
We used a 2-sample t test, analysis of variance, and chi-square analysis to 
= .12 to .83). Regression diagnostics were also performed on all multivariate models to detect any evidence of collinearity among the independent variables. Collinearity problems occur when any one independent variable reflects a near linear combination of one or more other independent variables in the model. Indicators of potential problems in this regard include a variance inflation factor greater than 10 and a condition index greater than 30, especially when the proportion of variance in the parameter estimate was greater than 0.5 (32). The statistical analyses were performed with the statistical package SAS version 9.2 (SAS Institute, Inc. Cary, NC) (33) . Cox proportional hazards were analyzed using the 'PHREG' procedure with the 'COVSANDWICH' option to account for the nesting of cases by medical center. In this option, the standard errors for the model parameters are computed using the robust 'sandwich' variance estimator of Lin and Wei (34) . We repeated the analysis to account for the nesting of cases by census tract, but results were essentially the same as those without the sandwich variance estimate.
RESULTS
Baseline characteristics and mortality outcomes of the cohort are summarized in Table 1 . Cases were followed on average for 8.6 years, with an overall mortality rate of 75.5 percent. Approximately forty percent of the deaths were due to prostate cancer The mechanisms underlying the association of area-level SES with prostate cancer-specific survival in these studies are not clear. However, in our study, the absence of the association in the VA suggests that healthcare system-related factors after diagnosis may be responsible. In fact, our findings suggest that a diagnosis of prostate cancer in an equal-access system protects against the adverse effects of areabased socioeconomic gradients on prostate cancer survival. These gradients may also associate with inappropriate variation in care after treatment, including the intensity of Our study has several important limitations. The cohort was derived from a case series at four Chicago area medical centers rather than a population-based sampling frame. As a result, the choice of medical centers could have exaggerated differences in census tract-level SES and survival between our African-American and non-Hispanic white case and between medical centers. Of note, our age-adjusted prostate cancer mortality hazard ratio for African Americans vs. non-Hispanic whites was 1.56 (95% CI = 1.14 to 2.14), which is comparable to that reported by others (1, 13, 14) . Also, we did not account for changes in tract-level SES between diagnosis and end of follow-up or patterns of care after first-course therapy and other post-treatment factors.
Consequently, we were not able use our data to further clarify potential mechanisms involved the association that we observed between census tract-level SES and prostate cancer-specific survival. Finally, the men in our study were largely diagnosed just prior to the introduction of the prostate specific antigen (PSA) test for screening and early detection. Consequently, our cohort had a higher proportion of men who were diagnosed at an advanced-stage than would be expected in the PSA era.
In conclusion, much work remains on identifying the social determinants of disparities in prostate cancer prognosis. In our study, the socioeconomic status of the census tract of residence at diagnosis predicted prostate cancer-specific survival independent of age, race/ethnicity, prognostic tumor parameters, comorbidities, and initial treatment. Tract-level SES also helped account for differences in cancer-specific survival observed between African Americans and non-Hispanic whites. Furthermore, being diagnosed in an equal access healthcare system mitigated the influence of census tract-level SES on survival. Healthcare system factors, patterns of cancer care, and tumor/host biology after initial treatment are plausible mediators of the association.
Unfortunately, data on these and other potential mediating relationships are scarce.
Future research should focus on identifying the underlying mechanisms for the association of census tract-level SES with prostate cancer-specific survival. The results of this study are consistent with the view that minimizing differences in healthcare access is a pathway to minimizing disparities in cancer control (44) . However, our results need to be corroborated using a population-based study design that is guided by an appropriate conceptual framework for identifying social disparities in prostate cancer. 
